Articles published by Starton Therapeutics Inc.

Starton Therapeutics to Participate in Spotlight Panel at BioFuture 2026

October 16, 2026

From Starton Therapeutics Inc.

Via Business Wire

Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I

November 03, 2023

From Starton Therapeutics Inc.

Via Business Wire

Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

October 04, 2023

From Starton Therapeutics Inc.

Via Business Wire

Tickers HWEL

Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple Myeloma

September 13, 2023

From Starton Therapeutics Inc.

Via Business Wire

Tickers HWEL

Starton Therapeutics Contracts Global Clinical Research Organization to Conduct STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma

July 10, 2023

From Starton Therapeutics Inc.

Via Business Wire

Tickers HWEL

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

June 12, 2023

From Starton Therapeutics Inc.

Via Business Wire

Tickers HWEL

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.